---
title: "Haier Biomedical: Cumulatively repurchased shares worth 84.1156 million yuan for employee incentives"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263959869.md"
description: "HAIER BIOMEDICAL announced that the company will repurchase shares through a centralized bidding trading method on January 13, 2025, with a repurchase fund of 100 million to 200 million yuan, for the employee stock ownership plan or equity incentive, with a deadline until January 13, 2026. As of October 31, 2025, a total of 2.5903 million shares have been repurchased, accounting for 0.8147% of the total share capital, with a repurchase amount of 84.1156 million yuan and a repurchase price of 29.86 to 34.69 yuan per share"
datetime: "2025-11-03T07:47:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263959869.md)
  - [en](https://longbridge.com/en/news/263959869.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263959869.md)
---

# Haier Biomedical: Cumulatively repurchased shares worth 84.1156 million yuan for employee incentives

HAIER BIOMEDICAL announced that the company will repurchase shares through a centralized bidding trading method on January 13, 2025, with a repurchase fund of 100 million to 200 million yuan, intended for employee stock ownership plans or equity incentives, with a deadline until January 13, 2026. As of October 31, 2025, a total of 2,590,300 shares have been repurchased, accounting for 0.8147% of the total share capital, with a repurchase amount of 84.1156 million yuan and a repurchase price of 29.86 to 34.69 yuan per share

### Related Stocks

- [688139.CN](https://longbridge.com/en/quote/688139.CN.md)

## Related News & Research

- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [05:54 ETTermHub™ Launches New Managed FHIR Offering for SDOs](https://longbridge.com/en/news/287042225.md)
- [Elron says Axonius tops $200 million ARR, doubles revenue in two years](https://longbridge.com/en/news/287069566.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)